Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Body mass index and the efficacy of needle-free jet injection for the administration of rapid-acting insulin analogs, a post hoc analysis.

de Galan BE, Engwerda EE, Abbink EJ, Tack CJ.

Diabetes Obes Metab. 2013 Jan;15(1):84-6. doi: 10.1111/j.1463-1326.2012.01666.x. Epub 2012 Aug 12.

PMID:
22830987
2.

Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology.

Engwerda EE, Abbink EJ, Tack CJ, de Galan BE.

Diabetes Care. 2011 Aug;34(8):1804-8. doi: 10.2337/dc11-0182. Epub 2011 Jun 29.

3.

A comparison of the pharmacodynamic profiles of jet-injected regular human insulin versus conventionally administered insulin aspart in healthy volunteers.

Engwerda EE, Tack CJ, de Galan BE.

Diabetes Res Clin Pract. 2016 Nov;121:86-90. doi: 10.1016/j.diabres.2016.09.001. Epub 2016 Sep 8.

PMID:
27662042
5.

Pharmacodynamic effects of the oral glucokinase activator AZD6370 after single doses in healthy volunteers assessed with euglycaemic clamp.

Sjöstrand M, Ericsson H, Hartford M, Norjavaara E, Eriksson JW.

Diabetes Obes Metab. 2013 Jan;15(1):35-41. doi: 10.1111/j.1463-1326.2012.01672.x. Epub 2012 Sep 9.

PMID:
22958202
6.

Insulin glulisine, a new rapid-acting insulin analogue, displays a rapid time-action profile in obese non-diabetic subjects.

Becker RH, Frick AD, Burger F, Potgieter JH, Scholtz H.

Exp Clin Endocrinol Diabetes. 2005 Sep;113(8):435-43.

PMID:
16151977
7.

Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes.

Engwerda EE, Tack CJ, de Galan BE.

Diabetes Care. 2013 Nov;36(11):3436-41. doi: 10.2337/dc13-0492. Epub 2013 Oct 2.

8.

U-100, pH-Neutral formulation of VIAject(®) : faster onset of action than insulin lispro in patients with type 1 diabetes.

Heinemann L, Nosek L, Flacke F, Albus K, Krasner A, Pichotta P, Heise T, Steiner S.

Diabetes Obes Metab. 2012 Mar;14(3):222-7. doi: 10.1111/j.1463-1326.2011.01516.x. Epub 2011 Nov 13.

PMID:
21981286
10.

Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes.

de Wit HM, Engwerda EE, Tack CJ, de Galan BE.

Diabetes Obes Metab. 2015 Nov;17(11):1093-9. doi: 10.1111/dom.12550. Epub 2015 Sep 23.

PMID:
26259978
11.

Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes.

Heise T, Nosek L, Bøttcher SG, Hastrup H, Haahr H.

Diabetes Obes Metab. 2012 Oct;14(10):944-50. doi: 10.1111/j.1463-1326.2012.01638.x. Epub 2012 Jul 10.

12.

Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes.

Cengiz E, Tamborlane WV, Martin-Fredericksen M, Dziura J, Weinzimer SA.

Diabetes Care. 2010 May;33(5):1009-12. doi: 10.2337/dc09-2118. Epub 2010 Feb 11.

13.
14.

Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection.

Taylor R, Home PD, Alberti KG.

Diabetes Care. 1981 May-Jun;4(3):377-9.

PMID:
7047114
15.

Glycemic control, reported pain and leakage with a 4 mm × 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis.

Hirsch LJ, Gibney MA, Li L, Bérubé J.

Curr Med Res Opin. 2012 Aug;28(8):1305-11. doi: 10.1185/03007995.2012.709181. Epub 2012 Jul 18.

PMID:
22762347
16.
17.

Similarity of pharmacodynamic effects of a single injection of insulin glargine, insulin detemir and NPH insulin on glucose metabolism assessed by 24-h euglycaemic clamp studies in healthy humans.

Sørensen LP, Brock B, Mengel A, Rungby J, Moller N, Nielsen S, Vølund A, Schmitz O.

Diabet Med. 2010 Jul;27(7):830-7. doi: 10.1111/j.1464-5491.2010.03026.x.

PMID:
20636965
18.

Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects.

Becker RH, Frick AD, Teichert L, Nosek L, Heinemann L, Heise T, Rave K.

Diabetes Obes Metab. 2008 Nov;10(11):1105-13. doi: 10.1111/j.1463-1326.2008.00874.x. Epub 2008 Mar 18.

PMID:
18355326
19.

Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.

Rave K, Heise T, Weyer C, Herrnberger J, Bender R, Hirschberger S, Heinemann L.

Diabet Med. 1998 Sep;15(9):747-51.

PMID:
9737803
20.

Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.

Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.

Diabetes. 1996 May;45(5):659-66. Erratum in: Diabetes 1996 Sep;45(9):1285.

PMID:
8621019

Supplemental Content

Support Center